---
$id: https://graph.org.ai/products/commodity/51384616
$type: Product
source: UNSPSC
code: "51384616"
title: "Pirazolac"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirazolac

**UNSPSC Code**: 51384616
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H12ClFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWY2578LP5, chemically known as 1h-pyrazole-3-acetic acid, 4-(4-chlorophenyl)-1-(4-fluorophenyl)- but generally known as pirazolac, which bears US NIH Compound Identifier 51222. European Medicines Agency schedules Pirazolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09898MIG. The term PIRAZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PIRAZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirazolac under HS 29331990 and SITC 51571. As of Q4 2014, PIRAZOLAC remains the US FDA Preferred Term for this commodity. Pirazolac bears US NLM identifiers UMLS ID C0071127 and NCI Concept Code C66413. SMILES: CLC1CCC(C2C(NN(C2)C2CCC(F)CC2)CC(=O)O)CC1.

